Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels
Ayumi Kanno, … , Masato Kasuga, Yoshiaki Kido
Ayumi Kanno, … , Masato Kasuga, Yoshiaki Kido
Published May 7, 2020
Citation Information: JCI Insight. 2020;5(9):e128820. https://doi.org/10.1172/jci.insight.128820.
View: Text | PDF
Research Article Endocrinology Metabolism

GCN2 regulates pancreatic β cell mass by sensing intracellular amino acid levels

  • Text
  • PDF
Abstract

EIF2AK4, which encodes the amino acid deficiency–sensing protein GCN2, has been implicated as a susceptibility gene for type 2 diabetes in the Japanese population. However, the mechanism by which GCN2 affects glucose homeostasis is unclear. Here, we show that insulin secretion is reduced in individuals harboring the risk allele of EIF2AK4 and that maintenance of GCN2-deficient mice on a high-fat diet results in a loss of pancreatic β cell mass. Our data suggest that GCN2 senses amino acid deficiency in β cells and limits signaling by mechanistic target of rapamycin complex 1 to prevent β cell failure during the consumption of a high-fat diet.

Authors

Ayumi Kanno, Shun-ichiro Asahara, Ayuko Furubayashi, Katsuhisa Masuda, Risa Yoshitomi, Emi Suzuki, Tomoko Takai, Maki Kimura-Koyanagi, Tomokazu Matsuda, Alberto Bartolome, Yushi Hirota, Norihide Yokoi, Yuka Inaba, Hiroshi Inoue, Michihiro Matsumoto, Kenichi Inoue, Takaya Abe, Fan-Yan Wei, Kazuhito Tomizawa, Wataru Ogawa, Susumu Seino, Masato Kasuga, Yoshiaki Kido

×

Figure 5

GCN2 phosphorylation is increased in pancreatic β cells when proinsulin mRNA translation is enhanced.

Options: View larger image (or click on image) Download as PowerPoint
GCN2 phosphorylation is increased in pancreatic β cells when proinsulin ...
(A) Immunoblot analysis of GCN2 phosphorylation in INS-1 cells that had been maintained in the presence of 2.8 mM glucose and then stimulated with 16.8 mM glucose, with 30 mM KCl plus 250 μM diazoxide (DZ), or with 500 μM tolbutamide (TLB) for 1 hour. (B) Immunoblot analysis of GCN2 phosphorylation in INS-1 cells that had been maintained in the presence of 2.8 mM glucose and then incubated for 1 hour in the presence of 2.8 or 16.8 mM glucose and the indicated concentrations of cycloheximide (CHX). (C) Cells treated as in A were analyzed for nascent translation of proinsulin mRNA by L-azidohomoalanine (AHA) labeling and immunoprecipitation with antibodies to insulin. (D) Immunoblot analysis of GCN2 phosphorylation in pancreatic islets isolated from 16-week-old WT mice that had been deprived of food overnight for 16 hours and then refed (or not) with normal chow for 2 hours. In all panels, representative blots and relative quantitative data (mean ± SEM) for at least 3 independent experiments are shown. *P < 0.05, **P < 0.01 (2-tailed Student’s t test).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts